Guldiken, S. Et Al. 2006. The effects of rosiglitazone treatment on the fibrinolytic system in patients with type 2 diabetes mellitus. CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS , vol.12, no.1 , 55-60.

Guldiken, S., Turgut, B., Demir, M., Arikan, E., Kara, M., Vural, O., ... Tugrul, A.(2006). The effects of rosiglitazone treatment on the fibrinolytic system in patients with type 2 diabetes mellitus. CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS , vol.12, no.1, 55-60.

Guldiken, S Et Al. "The effects of rosiglitazone treatment on the fibrinolytic system in patients with type 2 diabetes mellitus," CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS , vol.12, no.1, 55-60, 2006

Guldiken, S Et Al. "The effects of rosiglitazone treatment on the fibrinolytic system in patients with type 2 diabetes mellitus." CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS , vol.12, no.1, pp.55-60, 2006

Guldiken, S. Et Al. (2006) . "The effects of rosiglitazone treatment on the fibrinolytic system in patients with type 2 diabetes mellitus." CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS , vol.12, no.1, pp.55-60.

@article{article, author={S Guldiken Et Al. }, title={The effects of rosiglitazone treatment on the fibrinolytic system in patients with type 2 diabetes mellitus}, journal={CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS}, year=2006, pages={55-60} }